Advancing the Frontiers of Pediatric Cancer Research
Cincinnati Children’s is home to one of the nation’s most innovative pediatric cancer research programs, bringing together experts in oncology, hematology, immunology, stem cell biology, biomedical informatics, and precision medicine. Across our many divisions, centers, and laboratories, researchers are working to better understand the mechanisms of cancer and blood diseases, identify new therapeutic targets, and develop more effective treatments for children and young adults.
What distinguishes our approach is the close connection between basic, translational, and clinical research. Investigators and clinicians collaborate to move discoveries into care as efficiently as possible, supported by advanced technologies, robust clinical trial infrastructure, and a culture of scientific rigor. This integrated model accelerates our ability to identify molecular drivers of disease, explore novel cell and gene therapies, and refine treatment strategies that improve long-term outcomes.
Recent studies by our teams have mapped stem and progenitor cell populations with unprecedented precision, uncovered new vulnerabilities in treatment-resistant cancers, and introduced tools that expand the reach of cancer immunotherapy. Others are leading clinical research efforts in natural killer cell therapies, kinase inhibitor protocols for rare cancers, and proton therapy approaches that minimize harm to healthy tissue.
As you explore the cancer research ecosystem at Cincinnati Children’s, you’ll find a shared focus on advancing discovery, improving care, and training the next generation of scientific leaders. Our researchers are committed to solving some of the most pressing challenges in pediatric oncology and hematology—and translating that progress into real-world impact for patients and families around the world.
